Locations:
SearchAdvertisement
Minimal residual disease testing shows promising results
Insights on leveraging collaboration and advocacy to develop and conduct needed trials
Study calls attention to the need for screenings at age 40 or younger
Dispelling myths and sharing practical experiences
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Lack of appropriate testing remains a barrier for patients eligible for targeted treatment
Invasion of the lumbar spine and iliac vein made resection risky
Dysphagia and SUVmax are predictive, but other suspected factors are not
Research indicates strong rationale for expanding trial eligibility criteria
Fine-tuning radiation for recurrent cancers
A well-prepared team meets the distinctive needs of patients at hereditary high risk
Advertisement
Advertisement